As the indications for these medications broaden, so too does the patient population seeking plastic surgery
Ozempic: Approved by the FDA on June 4, 2021, for chronic weight management in patients with obesity (body mass index of 30 or more) and overweight (body mass index of 27 or more) with a weight-related condition like cardiovascular disease, high blood pressure, or type 2 diabetes
But its important to choose the medication based on your needs and your doctors prescription
The 0.9% concentration is calibrated to provide effective bacteriostasis at the anticipated microbial challenge levels associated with multi-use vial access in laboratory research environments while remaining below the concentration ranges associated with peptide and protein stability perturbation in reconstituted research compound solutions
Nicholls SJ, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, DAlessio DA, SURPASS-CVOT Investigators (2024) SURPASS-CVOT Investigators
